|
US5042723A
(en)
*
|
1986-09-01 |
1991-08-27 |
Imperial Chemical Industries Plc |
Electrostatic spraying apparatus
|
|
GB8621095D0
(en)
*
|
1986-09-01 |
1986-10-08 |
Ici Plc |
Electrostatic spraying apparatus
|
|
FI901390A0
(fi)
*
|
1987-09-22 |
1990-03-20 |
Ici Plc |
Elektrostatisk sprayanordning.
|
|
JP2587298B2
(ja)
*
|
1989-10-30 |
1997-03-05 |
オーベクス 株式会社 |
液体揮散装置
|
|
US5178330A
(en)
*
|
1991-05-17 |
1993-01-12 |
Ransburg Corporation |
Electrostatic high voltage, low pressure paint spray gun
|
|
US5605605A
(en)
*
|
1992-03-02 |
1997-02-25 |
Imperial Chemical Industries Plc |
Process for treating and sizing paper substrates
|
|
US5326598A
(en)
*
|
1992-10-02 |
1994-07-05 |
Minnesota Mining And Manufacturing Company |
Electrospray coating apparatus and process utilizing precise control of filament and mist generation
|
|
US5402945A
(en)
*
|
1993-01-22 |
1995-04-04 |
Gervan Company International |
Method for spraying plants and apparatus for its practice
|
|
US6703050B1
(en)
*
|
1998-09-04 |
2004-03-09 |
The Regents Of The University Of Michigan |
Methods and compositions for the prevention or treatment of cancer
|
|
US6397838B1
(en)
*
|
1998-12-23 |
2002-06-04 |
Battelle Pulmonary Therapeutics, Inc. |
Pulmonary aerosol delivery device and method
|
|
US6368562B1
(en)
|
1999-04-16 |
2002-04-09 |
Orchid Biosciences, Inc. |
Liquid transportation system for microfluidic device
|
|
EP1171243B1
(en)
|
1999-04-23 |
2006-08-16 |
Ventaira Pharmaceuticals, Inc. |
High mass transfer electrosprayer
|
|
US6485690B1
(en)
|
1999-05-27 |
2002-11-26 |
Orchid Biosciences, Inc. |
Multiple fluid sample processor and system
|
|
US6339107B1
(en)
|
2000-08-02 |
2002-01-15 |
Syntex (U.S.A.) Llc |
Methods for treatment of Emphysema using 13-cis retinoic acid
|
|
EP1935869A1
(en)
|
2000-10-02 |
2008-06-25 |
F. Hoffmann-La Roche Ag |
Retinoids for the treatment of emphysema
|
|
US20030181416A1
(en)
*
|
2002-01-10 |
2003-09-25 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
|
US20040009953A1
(en)
*
|
2002-01-10 |
2004-01-15 |
Comper Wayne D. |
Antimicrobial charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and method of use thereof
|
|
US7189865B2
(en)
*
|
2002-07-23 |
2007-03-13 |
Attenuon, Llc |
Thiomolybdate analogues and uses thereof
|
|
CN1688303A
(zh)
|
2002-07-23 |
2005-10-26 |
密歇根大学董事会 |
用于抗血管发生疗法的四硫代钼酸四丙铵及相关化合物
|
|
AU2003276987B2
(en)
*
|
2002-09-27 |
2009-07-30 |
Bioenvision, Inc. |
Methods and compositions for the treatment of lupus using clofarabine
|
|
US20060100167A1
(en)
*
|
2002-09-27 |
2006-05-11 |
Wood Christopher B |
Methods and compositions for the treatment of autoimmune disorders using clofarabine
|
|
EP1556056A4
(en)
*
|
2002-10-07 |
2008-08-06 |
Radiorx Inc |
X-Nitro Compounds, Pharmaceutical Compositions And Their Uses
|
|
EA200500871A1
(ru)
*
|
2002-11-25 |
2006-04-28 |
Атеньюон, Ллк |
Пептиды, ингибирующие ангиогенез, миграцию клеток, инвазию клеток и пролиферацию клеток, композиции и их применение
|
|
ZA200504940B
(en)
*
|
2003-01-28 |
2006-09-27 |
Xenoport Inc |
Amino acid derived prodrugs of propofol, compositions and uses thereof
|
|
ES2436606T3
(es)
|
2003-03-12 |
2014-01-03 |
Celgene Corporation |
Compuestos de 7-amido-isoindolilo y sus usos farmacéuticos
|
|
CN104056278B
(zh)
|
2003-04-11 |
2017-01-18 |
Ptc 治疗公司 |
1,2,4‑噁二唑苯甲酸化合物
|
|
BRPI0410651A
(pt)
*
|
2003-05-27 |
2006-07-04 |
Attenuon Llc |
composto, composição farmacêutica, e, métodos para tratar ou prevenir cáncer, degeneração macular do tipo úmida ou artrite reumatóide, vascularização aberrante, nìveis de cobre em excesso, obesidade e doença neurodegenerativa em um paciente
|
|
WO2005004882A1
(en)
*
|
2003-07-09 |
2005-01-20 |
Monash University |
Antiviral charged polymers that exhibit resistance to lysosomal degradation during kidney filtration and renal passage, compositions and methods of use thereof
|
|
US7230003B2
(en)
*
|
2003-09-09 |
2007-06-12 |
Xenoport, Inc. |
Aromatic prodrugs of propofol, compositions and uses thereof
|
|
EP1692128A1
(en)
|
2003-11-19 |
2006-08-23 |
Signal Pharmaceuticals LLC |
Indazole compounds and methods of use thereof as protein kinase inhibitors
|
|
WO2005082382A1
(en)
*
|
2004-02-23 |
2005-09-09 |
Attenuon Llc |
Formulations of thiomolybdate or thiotungstate compounds and uses thereof
|
|
ES2315897T3
(es)
*
|
2004-07-12 |
2009-04-01 |
Xenoport, Inc. |
Aminoacidos derivados de porfarmacos de composiciones de propofol y usos del mismo.
|
|
US7241807B2
(en)
*
|
2004-07-12 |
2007-07-10 |
Xenoport, Inc. |
Prodrugs of propofol, compositions and uses thereof
|
|
US20060128676A1
(en)
*
|
2004-07-13 |
2006-06-15 |
Pharmacofore, Inc. |
Compositions of nicotinic agonists and therapeutic agents and methods for treating or preventing diseases or pain
|
|
EP2561872B1
(en)
|
2004-12-17 |
2014-09-10 |
Anadys Pharmaceuticals, Inc. |
3, 5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO [4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
|
|
EP1844000B1
(en)
*
|
2004-12-23 |
2010-01-27 |
Xenoport, Inc. |
Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
|
|
CA2596357A1
(en)
|
2005-02-01 |
2006-08-10 |
Attenuon, Llc |
Acid addition salts of ac-phscn-nh2
|
|
US7507842B2
(en)
|
2005-08-12 |
2009-03-24 |
Radiorx, Inc. |
Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
US20070135380A1
(en)
|
2005-08-12 |
2007-06-14 |
Radiorx, Inc. |
O-nitro compounds, pharmaceutical compositions thereof and uses thereof
|
|
EP1928881A2
(en)
|
2005-08-19 |
2008-06-11 |
Pharmacofore, Inc. |
Prodrugs of active agents
|
|
MX2008012064A
(es)
*
|
2006-03-23 |
2008-12-17 |
Amgen Inc |
Compuestos de amida 1-fenilsulfonil-diaza-heterociclica y sus usos como moduladores de hidroxiesteroide deshidrogenadas.
|
|
RU2469038C2
(ru)
|
2006-05-26 |
2012-12-10 |
Фармакофор, Инк. |
Контролируемое высвобождение фенольных опиатов
|
|
ES2349887T3
(es)
*
|
2006-06-08 |
2011-01-12 |
Amgen Inc. |
Derivados de benzamida y usos relacionados con los mismos.
|
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
|
TWI418561B
(zh)
|
2006-06-22 |
2013-12-11 |
Anadys Pharmaceuticals Inc |
５-胺基-３-（３’-去氧-β-Ｄ-核糖呋喃糖基（ｒｉｂｏｆｕｒａｎｏｓｙｌ））-噻唑并〔４，５-ｄ〕嘧啶-２，７-二酮之前藥
|
|
MX2008016519A
(es)
|
2006-06-22 |
2009-01-30 |
Anadys Pharmaceuticals Inc |
Compuestos de pirro[1,2,-b]piridazinona.
|
|
US7528115B2
(en)
|
2006-07-18 |
2009-05-05 |
Anadys Pharmaceuticals, Inc. |
Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidines
|
|
EP2051977A2
(en)
*
|
2006-07-20 |
2009-04-29 |
Amgen Inc. |
SUBSTITUTED AZOLE AROMATIC HETEROCYCLES AS INHIBITORS OF LLbeta-HSD-1
|
|
US7673820B2
(en)
*
|
2006-12-18 |
2010-03-09 |
Yehuda Ivri |
Subminiature thermoelectric fragrance dispenser
|
|
US7932421B2
(en)
*
|
2006-12-26 |
2011-04-26 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
|
US8633186B2
(en)
|
2007-06-08 |
2014-01-21 |
Senomyx Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US9603848B2
(en)
*
|
2007-06-08 |
2017-03-28 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
US7928111B2
(en)
*
|
2007-06-08 |
2011-04-19 |
Senomyx, Inc. |
Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors
|
|
US20080306076A1
(en)
*
|
2007-06-08 |
2008-12-11 |
Senomyx, Inc. |
Modulation of chemosensory receptors and ligands associated therewith
|
|
WO2009003061A1
(en)
|
2007-06-25 |
2008-12-31 |
Fred Hutchinson Cancer Research Center |
Methods and compositions regarding polychalcogenide compositions
|
|
CN101778563B
(zh)
|
2007-08-10 |
2014-07-16 |
Vm生物医药公司 |
调节细胞凋亡的组合物和方法
|
|
ES2647947T3
(es)
|
2008-07-31 |
2017-12-27 |
Senomyx, Inc. |
Procesos y productos intermedios para la preparación de potenciadores del sabor dulce
|
|
BRPI0916550B1
(pt)
|
2008-07-31 |
2020-09-15 |
Firmenich Incorporated |
Composições que compreendem intensificadores de doçura e métodos de produção das mesmas
|
|
TWI480272B
(zh)
|
2008-10-09 |
2015-04-11 |
Anadys Pharmaceuticals Inc |
藉由５，６－二氫－１ｈ－吡啶－２－酮與一或多種其他抗病毒化合物的組合物抑制ｃ型肝炎病毒的方法
|
|
SMT202000257T1
(it)
|
2008-10-10 |
2020-07-08 |
Vm Discovery Inc |
Composizioni e metodi per il trattamento dei disturbi da uso di alcol, dolore e altre malattie
|
|
WO2010077680A2
(en)
|
2008-12-08 |
2010-07-08 |
Vm Discovery Inc. |
Compositions of protein receptor tyrosine kinase inhibitors
|
|
FR2950545B1
(fr)
*
|
2009-09-29 |
2012-11-30 |
Centre Nat Rech Scient |
Dispositif et procede de projection electrostatique d'un liquide, injecteur de carburant incorporant ce dispositif et utilisations de ce dernier
|
|
US8471041B2
(en)
*
|
2010-02-09 |
2013-06-25 |
Alliant Techsystems Inc. |
Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same
|
|
WO2012021837A2
(en)
|
2010-08-12 |
2012-02-16 |
Senomyx, Inc. |
Method of improving stability of sweet enhancer and composition containing stabilized sweet enhancer
|
|
US9327037B2
(en)
|
2011-02-08 |
2016-05-03 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
US20120321590A1
(en)
|
2011-04-06 |
2012-12-20 |
Anadys Pharmaceuticals, Inc. |
Bridged polycyclic compounds
|
|
US8664247B2
(en)
|
2011-08-26 |
2014-03-04 |
Radiorx, Inc. |
Acyclic organonitro compounds for use in treating cancer
|
|
US20140308260A1
(en)
|
2011-10-07 |
2014-10-16 |
Radiorx, Inc. |
Methods and compositions comprising a nitrite-reductase promoter for treatment of medical disorders and preservation of blood products
|
|
US9139519B2
(en)
|
2011-10-07 |
2015-09-22 |
Epicentrx, Inc. |
Organonitro thioether compounds and medical uses thereof
|
|
US8586527B2
(en)
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
|
BR112014014262A2
(pt)
|
2011-12-14 |
2017-06-13 |
Univ Johns Hopkins |
nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
|
|
CN110664816A
(zh)
|
2012-06-07 |
2020-01-10 |
佐治亚州立大学研究基金会公司 |
Seca抑制剂以及其制备和使用方法
|
|
HK1209728A1
(en)
|
2012-08-06 |
2016-04-08 |
Firmenich Incorporated |
Sweet flavor modifier
|
|
RU2768868C2
(ru)
|
2012-09-27 |
2022-03-25 |
Дзе Чилдрен'З Медикал Сентер Корпорейшн |
Соединения, предназначенные для лечения ожирения, и способы их применения
|
|
JO3155B1
(ar)
|
2013-02-19 |
2017-09-20 |
Senomyx Inc |
معدِّل نكهة حلوة
|
|
WO2015081093A1
(en)
|
2013-11-26 |
2015-06-04 |
The Chilren's Medical Center Corporation |
Compounds for the treatment of obesity and methods of use thereof
|
|
CA2934043C
(en)
|
2014-02-05 |
2019-03-12 |
VM Oncology LLC |
Trka receptor tyrosine kinase antagonists and uses thereof
|
|
US20170209408A1
(en)
|
2014-04-03 |
2017-07-27 |
The Children's Medical Center Corporation |
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
|
|
EP3355885A4
(en)
|
2015-10-01 |
2019-04-24 |
Elysium Therapeutics, Inc. |
MULTI-SUBUNIT OPIOID PRODRUGS WITH RESISTANCE TO OVERDOSE AND MISUSE
|
|
US10335406B2
(en)
|
2015-10-01 |
2019-07-02 |
Elysium Therapeutics, Inc. |
Opioid compositions resistant to overdose and abuse
|
|
US10342778B1
(en)
|
2015-10-20 |
2019-07-09 |
Epicentrx, Inc. |
Treatment of brain metastases using organonitro compound combination therapy
|
|
US9987270B1
(en)
|
2015-10-29 |
2018-06-05 |
Epicentrix, Inc. |
Treatment of gliomas using organonitro compound combination therapy
|
|
SG11201805942UA
(en)
|
2016-01-11 |
2018-08-30 |
Epicentrx Inc |
Compositions and methods for intravenous administration of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone
|
|
JP7332469B2
(ja)
|
2016-10-14 |
2023-08-23 |
エピセントアールエックス，インコーポレイテッド |
スルホキシアルキル有機窒素および関連のある化合物ならびに医学における使用のための医薬組成物
|
|
EP3595663A4
(en)
|
2017-03-17 |
2021-01-13 |
Elysium Therapeutics, Inc. |
MULTI-UNIT OPIOID MEDICINES RESISTANT TO OVERDOSE AND ABUSE
|
|
AU2018297348B2
(en)
|
2017-07-07 |
2024-07-25 |
Epicentrx, Inc. |
Compositions for parenteral administration of therapeutic agents
|
|
US11510901B2
(en)
|
2018-01-08 |
2022-11-29 |
Epicentrx, Inc. |
Methods and compositions utilizing RRx-001 combination therapy for radioprotection
|
|
WO2019200274A1
(en)
|
2018-04-12 |
2019-10-17 |
MatRx Therapeutics Corporation |
Compositions and methods for treating elastic fiber breakdown
|
|
EP3814344B1
(en)
|
2018-08-07 |
2024-07-24 |
Firmenich Incorporated |
5-substituted 4-amino-1h-benzo[c][1,2,6]thiadiazine 2,2-dioxides and formulations and uses thereof
|
|
WO2020235812A1
(ko)
*
|
2019-05-17 |
2020-11-26 |
주식회사 이서 |
미세 입자 농도를 관리하기 위한 장치 및 방법
|
|
US12211684B2
(en)
|
2019-10-31 |
2025-01-28 |
New Objective, Inc. |
Method and device for improved performance with micro-electrospray ionization
|
|
US11980907B2
(en)
|
2021-05-20 |
2024-05-14 |
Climb Works LLC |
Electrostatic sprayer
|
|
CN114308433B
(zh)
*
|
2021-12-20 |
2024-01-05 |
江苏大学 |
一种气力辅助静电喷头
|
|
WO2023178283A1
(en)
|
2022-03-18 |
2023-09-21 |
Epicentrx, Inc. |
Co-crystals of 2-bromo-1-(3,3-dinitroazetidin-1-yl)ethanone and methods
|
|
WO2023215229A1
(en)
|
2022-05-02 |
2023-11-09 |
Epicentrx, Inc. |
Compositions and methods for treatment of pulmonary hypertension
|
|
US20250288555A1
(en)
|
2022-05-02 |
2025-09-18 |
Epicentrx, Inc. |
Systems and methods to improve exercise tolerance
|
|
TW202408485A
(zh)
|
2022-06-13 |
2024-03-01 |
美商埃皮辛特瑞科斯公司 |
用於減少癌症治療中不良副作用之組合物及方法
|
|
WO2024098009A1
(en)
|
2022-11-04 |
2024-05-10 |
Epicentrx, Inc. |
Rrx-001 for minimizing post-infarct adverse ventricular remodeling and complications
|
|
WO2024124152A1
(en)
|
2022-12-08 |
2024-06-13 |
Epicentrx, Inc. |
Rrx-001 for the treatment of a hemoglobinopathy
|